6/5/2018. Asthma. What is Asthma? Asthma effects 8.1 million children in the United States and rising
|
|
- Charlene Stevens
- 5 years ago
- Views:
Transcription
1 ASTHMA Asthma Statistics in the United States In 2016, an estimated 25.9 million people suffered from asthma 1 In comparison, approximately: 27 million had heart disease 2 * 25.8 million had diabetes million had cancer 4 In 2016, asthma prevalence was % in African Americans 8% in Caucasians 7.2% in Hispanics Marc W. Cromie, Sr.,M.D. Pediatric and Adult allergy, Asthma &Immunology Chattanooga Allergy Clinic Asthma costs the U.S. economy more than $80 billion annually in medical expenses, missed work days and death, according to new research published in the Annals of the American Thoracic Society. *Heart disease includes coronary heart disease, angina pectoris, heart attack, or any other heart condition or disease in patients aged 18 and older. Includes any person alive on January 1, 2009, who had been diagnosed at any sites with active disease and those who were cured. 1. American Lung Association, Epidemiology and Statistics Unit, Research and Program Services Division. Trends in Asthma Morbidity and Mortality. September Accessed April 17, Pleis JR et al. Vital Health Stat. 10(249) Accessed April 17, US Centers for Disease Control and Prevention. Accessed April 17, National Cancer Institute Surveillance Epidemiology and End Results. Accessed April 17, Barnett SB et al. Costs of Asthma in the United States: J Allergy Clin Immunol. 2011;127(1): Asthma Remains a Serious Health Risk in the United States 14.4 million missed school days due to asthma 14.2 million missed work days due to asthma 11.7 million asthma-related healthcare visits 2.1 million asthma-related emergency department visits *Data represented ranges from Annually in the US, approximately...* 439,000 asthma-related hospitalizations 3,388 deaths due to asthma Asthma Asthma effects 8.1 million children in the United States and rising Most common chronic disease in kids and most common cause of school absenteeism Most children with asthma develop asthma symptoms before age 5 American Lung Association, Epidemiology and Statistics Unit, Research and Program Services Division. Trends in Asthma Morbidity and Mortality. September Accessed April 17, What is Asthma? A Chronic, Obstructive, Reversible airways disease characterized by Inflammation, Mucus Secretion, and Bronchoconstriction. 1
2 Pathophysiology Symptoms Cough, wheeze, SOB, increase respiratory rate or work of breathing, chest tightness Fatigue- the child will stop playing, slow down, avoid certain activities Infant may have difficulty feeding, grunt during sucking Symptoms are worse at night and early morning Worse with viral infections, exposure to allergens and irritants (smoke), exercise, emotions, and changes in weather or humidity Worse with activity The Dreaded Cough How do you diagnose asthma? COUGHING ALONE CAN BE ASTHMA!!!! -The patient may NEVER wheeze -Think asthma when the parents say. he coughs at night all the time when she gets a normal cold, she gets such a bad cough, and keeps it longer after running and playing, he seems to start coughing and comes inside she coughs when she s at her grandma s There is no perfect test for diagnosing asthma Can be quite difficult History Physical exam Pulmonary Function Testing FENO (Fractionated Exhaled Nitric Oxide) Response to medications Spirometry FeNO Testing as a Tool to Aid in Implementing Asthma Treatment Guidelines Diagnosis and Initiating Therapy Circassia Pharmaceuticals
3 LOW FeNO level FeNO Interpretation 1 INTERMEDIATE/ INCREASING FeNO level* HIGH FeNO level Inhaled steroids. <25 ppb in adults <20 ppb in children Eosinophilic inflammation less likely Symptomatic patients unlikely to benefit from trial of or additional ICS therapy; consider other possible etiologies ppb in adults ppb in children Cautious interpretation; based on clinical judgment, consider initiating trial of or increasing ICS therapy/adherence and monitor change in FeNO levels >50 ppb in adults >35 ppb in children Eosinophilic inflammation likely Symptomatic patients likely to benefit from trial or increase in ICS/anti-Th2 therapy; investigate allergen exposure Treats the Inflammation and Mucus Secretion in Asthma Remember, albuterol does not treat inflammation at all! Zero! Nothing! Preventative medication FeNO, fractional exhaled nitric oxide; GERD, gastroesophageal reflux disease. *Increasing defined as >40% increase from previous stable FeNO level. Chronic cough and/or wheeze and/or shortness of breath for >6 weeks. For example, rhinosinusitis, bronchiectasis, primary ciliary dyskinesia, anxiety-hyperventilation, cardiac disease, GERD, or vocal cord Circassia dysfunction. Pharmaceuticals Dweik et al. Am J Respir Crit Care Med. 2011;184: Other meds Rescue Inhalers Montelukast ICS/LABA combo LAMA Biologics/monoclonal Abs Omalizumab=Xolair Mepolizumab=Nucala Reslizumab=Cinqair Benralizumab=Fasenra Bronchodilators Ventolin, ProAir, Proventil, Xopenex Relax muscles around the airway Rescue medication only Puffers should be used with a spacer Can be nebulized as well Albuterol How to administer albuterol I write for 2-4 puffs every 4-6 hours as needed 1 puff every 30 seconds ER studies suggest 6-8 puffs equals 1 nebulizer treatment 1 puff of albuterol = 90 mcg 1 nebulizer vial = 2.5 mg albuterol 3
4 Patients, % (Weighted Prevalence) % of Patients With Uncontrolled Asthma Side effects Jittery, increased heart rate, nervous feeling Should help in about 5 minutes Can use a spacer or not Are Patients in the United States Achieving Asthma Control on Their Current Therapy? Asthma Control of Adults in Primary Care Objective To evaluate the level of uncontrolled asthma in adult patients Study Design Cross-sectional, epidemiological survey administered at 35 geographically distributed primary care provider (PCP) sites across the US 2238 adults ( 18 years of age) with a self-reported physician diagnosis of asthma Brief, self-administered questionnaire included: The validated ASTHMA CONTROL TEST and Questions about demographics, health behaviors, medical history, current asthma medication use, and reason for current PCP visit Survey was conducted from January 25, 2008, to May 2, 2008 Asthma Control of Adults in Primary Care Age (Years), Mean (SD) 46.7 (15.7) 46.3 (15.9) 46.7 (15.7) Female n (%) 1601 (72%) 602 (70%) 935 (73%) Race/ethnicity n (%) Caucasian 1483 (68%) 557 (66%) 877 (69%) African American 262 (12%) 97 (11%) 154 (12%) Hispanic 246 (11%) 119 (14%) 118 (9%) Others 206 (9%) 74 (9%) 119 (9%) Patient-described severity n (%) Mild 1061 (49%) 324 (39%) 708 (56%) Moderate 971 (45%) 434 (52%) 497 (40%) Severe 137 (6%) 79 (9%) 51 (4%) Body mass index Overall N=2238 Respiratory Visits N=861 Nonrespiratory Visits N=1289 <20 kg/m 2 63 (3%) 29 (4%) 33 (3%) kg/m (48%) 388 (47%) 607 (49%) >30 kg/m (49%) 410 (50%) 598 (48%) ASTHMA CONTROL TEST is a trademark of QualityMetric Incorporated. Mintz M et al. Curr Med Res Opin. 2009;25(10): SD=standard deviation Mintz M et al. Curr Med Res Opin. 2009;25(10): % of Adults With Asthma Visiting a PCP for Any Reason Had Uncontrolled Asthma Nearly Half of Patients With Asthma Visiting a PCP for a Nonrespiratory Reason Had Uncontrolled Asthma % 80% 72% 70% % 60% 50% 58% 48% 30 40% 20 30% 10 20% 0 Controlled Uncontrolled 10% Results are from a cross-sectional epidemiological survey conducted between January 25 and May 2, 2008, among patients in PCP offices, regardless of reason for visit. Data are presented for 2238 adults with a self-reported physician diagnosis of asthma. Patient asthma was classified as uncontrolled if ASTHMA CONTROL TEST score was 19. 0% Total Respiratory Reason Nonrespiratory Reason Results are from a cross-sectional epidemiological survey conducted between January 25 and May 2, 2008, among patients in PCP offices, regardless of reason for visit. Data are presented for 2238 adults with a self-reported physician diagnosis of asthma. Patient asthma was classified as uncontrolled if ASTHMA CONTROL TEST score was 19. Mintz M et al. Curr Med Res Opin. 2009;25(10): Mintz M et al. Curr Med Res Opin. 2009;25(10):
5 How Much Rescue Medication Are Asthma Patients Using? Use of SABA >2 days a week for symptom relief (not prevention of exerciseinduced bronchospasm) generally indicates inadequate control and the need to step up treatment. 1 Use of a SABA several times per day may indicate very poorly controlled asthma. 1 Overuse of SABA is a risk factor for subsequent exacerbations. Requiring ED visits, hospitalizations, and/or oral corticosteroid dispensing 2,3 Most albuterol inhalers have 200 puffs per canister, equaling 100 doses* If a patient uses 2 doses per week, a canister will last approximately 1 year If a patient uses 1 dose per day, the patient would use approximately 4 canisters per year 2007 National Heart, Lung, and Blood Institute Asthma Guidelines SABA = short-acting beta 2-agonists *Calculation for canister containing 200 inhalations, with patient using 2 inhalations per dose. Additional puffs may be required for priming of the canister. 1. National Heart, Lung, and Blood Institute. National Asthma Education and Prevention Program. asthgdln.htm. Accessed April 17, Schatz M et al. Chest. 2006;130: Schatz M et al. J Allergy Clin Immunol. 2006;117(5): Definitions: Severity, Control, and Responsiveness Assessment and monitoring of asthma are closely linked to the concepts of severity, control, and responsiveness Severity Control Responsiveness The intrinsic intensity of the disease process; most easily and directly measured in a patient who is not currently receiving long-term control medications (eg, ICSs) The degree to which the manifestations of asthma (symptoms, functional impairments, and risks of untoward events) are minimized and the goals of therapy are met The ease with which control is achieved by therapy The Goals of Asthma Therapy Reduce Impairment Prevent chronic and troublesome symptoms Require infrequent use ( 2 days/week) of short-acting beta 2 -agonists (SABA) for symptom relief Maintain (near) normal pulmonary function Maintain normal activity levels Meet patients and families expectation of, and satisfaction with, asthma care Reduce Risk Prevent recurrent exacerbations of asthma and minimize the need for emergency department visits or hospitalizations Prevent progressive loss of lung function; for children, prevent reduced lung growth Provide optimal pharmacotherapy with minimal or no adverse effects ICS=inhaled corticosteroid. National Heart, Lung, and Blood Institute. National Asthma Education and Prevention Program. Accessed April 17, National Heart, Lung, and Blood Institute. National Asthma Education and Prevention Program. Accessed April 17, Assessing Asthma Severity and Control Assessing Severity (Patients Aged 5 Years) Patients not currently taking long-term asthma control medications (eg, ICSs) Assess asthma severity Initiate/maintain/adjust asthma therapy Patients taking long-term asthma control medications (eg, ICSs) Assess asthma control Assess Impairment (based on patient s/caregiver s recall of previous 2 to 4 weeks and spirometry) Symptoms Nighttime awakenings SABA use for symptom control (not prevention of EIB) Interference with normal activity Lung function FEV 1, FEV 1/FVC Risk Exacerbations requiring oral systemic corticosteroids Classifying Severity Assign to the most severe category in which any feature occurs Intermittent Mild Persistent Moderate Persistent Severe Persistent EIB=exercise-induced bronchospasm; FEV 1=forced expiratory volume in 1 second; FVC=forced vital capacity. Adapted from: National Heart, Lung, and Blood Institute. National Asthma Education and Prevention Program. Accessed April 17, National Heart, Lung, and Blood Institute. National Asthma Education and Prevention Program. Accessed April 17,
6 Classifying Asthma Severity: Children 5 to 11 Years of Age Components of Severity Classification of Asthma Severity: Children 5 11 Years of Age Who Are Not Currently Taking Long-Term Asthma Control Medication Persistent Classifying Asthma Severity: Youths 12 Years of Age and Adults Components of Severity Classification of Asthma Severity: Youths 12 Years of Age and Adults Who Are Not Currently Taking Long-Term Asthma Control Medication Persistent Impairment Intermittent Mild Moderate Severe >2 days/week Symptoms Daily Throughout the day but not daily > 1x/week Nighttime awakenings 2x/month 3 4x/month Often 7x/week but not nightly Short-acting beta 2-agonist >2 days/week use for symptom control Daily Several times per day but not daily (not prevention of EIB) Interference with normal activity None Minor limitation Some limitation Extremely limited Normal FEV between FEV 1= 60%-80% 1 exacerbations FEV 1= >80% predicted predicted FEV 1 < 60% predicted Lung function FEV 1>80% predicted FEV 1/FVC >80% FEV 1/FVC = FEV 1/FVC <75% FEV 1/FVC >85% 75% 80% Impairment Normal FEV 1/FVC: 8 19 y 85% y 80% y 75% y 70% Intermittent Mild Moderate Severe >2 days/week Symptoms Daily Throughout day (not daily) >1 time/week Nighttime awakenings 2 times/month 3 to 4 times/month Often 7 times/week (not nightly) SABA use for symptom >2 days/week control (not prevention Daily Several times daily (not daily and not more of EIB) than 1x on any day) Interference with normal activity None Minor limitation Some limitation Extremely limited Normal FEV 1 between FEV 1 <60% FEV 1 >60% but <80% exacerbations FEV 1 >80% predicted predicted Lung function predicted FEV >80% predicted FEV 1/FVC normal FEV 1/FVC 1 FEV 1/FVC reduced 5% FEV 1/FVC normal reduced >5% 0 1/year* 2/year* Exacerbations requiring oral Consider severity and interval since last exacerbation Risk systemic corticosteroids Frequency and severity may fluctuate over time for patients in any severity category Relative annual risk of exacerbations may be related to FEV 1 Level of severity is determined by both impairment and risk. Assess impairment domain by patient's/caregiver's recall of the previous 2 to 4 weeks and spirometry. Assign severity to the most severe category in which any feature occurs. Adapted from the NIH guidelines. *At present, there are inadequate data to correspond frequencies of exacerbations with different levels of asthma severity. In general, more frequent and intense exacerbations (eg, requiring urgent, unscheduled care, hospitalization, or ICU admission) indicate greater underlying disease severity. For treatment purposes, patients who had 2 exacerbations requiring oral systemic corticosteroids in the past year may be considered the same as patients who have persistent asthma, even in the absence of impairment levels consistent with persistent asthma. National Heart, Lung, and Blood Institute. National Asthma Education and Prevention Program. Accessed April 17, to 1/year* 2 /year* Exacerbations Consider severity and interval since last exacerbation Risk requiring oral systemic Frequency and severity may fluctuate over time corticosteroids Relative annual risk of exacerbations may be related to FEV 1 Level of severity is determined by both impairment and risk. Assess impairment domain by patient s/caregiver s recall of the previous 2 to 4 weeks and spirometry. Assign severity to the most severe category in which any feature occurs. Adapted from the NIH guidelines. *At present, there are inadequate data to correspond frequencies of exacerbations with different levels of asthma severity. In general, more frequent and intense exacerbations (eg, requiring urgent, unscheduled care, hospitalization, or ICU admission) indicate greater underlying disease severity. For treatment purposes, patients who had 2 exacerbations requiring oral systemic corticosteroids in the past year may be considered the same as patients who have persistent asthma, even in the absence of impairment levels consistent with persistent asthma. National Heart, Lung, and Blood Institute. National Asthma Education and Prevention Program. Accessed April 17, Assessing Control (Children Aged 5-11 years) Assess Impairment (based on patient s/caregiver s recall of previous 2 to 4 weeks and spirometry) Symptoms Nighttime awakenings Interference with normal activity SABA use for symptom control (not prevention of exercise-induced bronchospasm [EIB]) Lung function FEV 1 or peak flow; FEV 1/FVC Risk Exacerbations requiring oral systemic corticosteroids Reduction in lung growth Treatment-related adverse effects Classifying Control Assign to most severe category in which any feature occurs Well Controlled Not Well Controlled Very Poorly Controlled Assessing Control (Patients Aged 12 years) Assess Impairment (based on patient s recall of previous 2 to 4 weeks and spirometry) Symptoms Nighttime awakenings Interference with normal activity SABA use for symptom control (not prevention of exercise-induced bronchospasm [EIB]) Validated questionnaire ATAQ, ACQ, ASTHMA CONTROL TEST Lung function FEV 1 or peak flow Risk Exacerbations requiring oral systemic corticosteroids Progressive loss of lung function Treatment-related adverse effects Classifying Control Assign to most severe category in which any feature occurs Well Controlled Not Well Controlled Very Poorly Controlled National Heart, Lung, and Blood Institute. National Asthma Education and Prevention Program. Accessed April 17, ATAQ=Asthma Therapy Assessment Questionnaire; ACQ=Asthma Control Questionnaire. National Heart, Lung, and Blood Institute. National Asthma Education and Prevention Program. Accessed April 17, Classifying Asthma Control: Children 5 to 11 Years of Age Components of Control Symptoms Classification of Asthma Control: Children 5 11 Years of Age Well Controlled Not Well Controlled Very Poorly Controlled but not more than once on each day >2 days/week or multiple times on Throughout the day Nighttime awakenings 1x/month 2x/month 2x/week Classifying Asthma Control: Youths 12 Years of Age and Adults Components of Control Symptoms Classification of Asthma Control: Youths 12 Years of Age and Adults Well Controlled Not Well Controlled Very Poorly Controlled but not more than once on each day >2 days/week Throughout the day Nighttime awakenings 2 2 times/month 1 to 3 times/week 4x/week Interference with normal activity None Some limitation Extremely limited Impairment Interference with normal activity None Some limitation Extremely limited Short-acting beta 2-agonist use for >2 days/week Several times per day symptom control (not prevention of EIB) Impairment SABA use for symptom control (not prevention of EIB) FEV 1 or peak flow 2 >2 days/week Several times per day >80% predicted/ 60% to 80% predicted/ <60% predicted/ 80% Lung function: FEV 1 or peak flow FEV 1/FVC >80% predicted or >80% predicted 60% 80% predicted or 75% 80% predicted <60% predicted or <75% predicted Validated questionnaires Asthma Therapy Assessment Questionnaire Asthma Control Questionnaire ASTHMA CONTROL TEST * 20 1 to to 19 3 to 4 NA 15 Risk Exacerbations requiring oral systemic corticosteroids Reduction in lung growth Treatment-related adverse effects 0 1/year 2/year Consider severity and interval since last exacerbation Evaluation requires long-term follow-up Medication side effects can vary in intensity from none to very troublesome and worrisome. The level of intensity does not correlate to specific levels of control but should be considered in the overall assessment of risk. Risk Exacerbations requiring oral systemic corticosteroids Progressive loss of lung function Treatment-related adverse effects 0 to 1/year 2/year Consider severity and interval since last exacerbation Consider severity and interval since last exacerbation Evaluation requires long-term follow-up care Medication Evaluation side effects requires can long-term vary in intensity follow-up care from none to very troublesome and worrisome. The level of intensity does not Medication side effects can vary in intensity from none to very troublesome correlate and worrisome. to specific The level levels of intensity of control does not but correlate should to be specific considered levels of control but should in the be overall considered assessment in the overall of assessment risk. of risk. Adapted from the NIH guidelines. National Heart, Lung, and Blood Institute. National Asthma Education and Prevention Program. Accessed April 17, Values of 0.76 to 1.4 are indeterminate regarding well-controlled asthma. Adapted from the NIH guidelines. National Heart, Lung, and Blood Institute. National Asthma Education and Prevention Program. Accessed April 17,
7 Clinical Assessments Before Stepping Up or Stepping Down Asthma Therapy Regular follow-up contacts at 1- to 6-month intervals, depending on the level of control Consider 3-month intervals if a step down in therapy is anticipated Step up if necessary; step down if possible Stepping Up Stepping Down Assessing Asthma Control in Children, Adolescents, and Adults Symptoms Nighttime awakenings Interference with normal activity NIH Criteria for Well-Controlled Asthma: Impairment Domain SABA use for symptom control (not prevention of EIB) 2 times/month (youths 12 years and adults) 1 time/month (children 5 to 11 years) None Review adherence, inhaler technique, environmental control, and comorbid conditions. If alternative* treatment option is used in a step, and asthma is still uncontrolled, discontinue and use preferred* medication before stepping up If a clear and positive response for 3 months:. Attempt a careful step down to identify the lowest dose required to maintain control FEV 1 or peak flow FEV 1/FVC Validated questionnaires (adults and adolescents only) Asthma Therapy Assessment Questionnaire Asthma Control Questionnaire ASTHMA CONTROL TEST Patients with asthma need to meet all criteria to be considered well controlled. * Values of 0.76 to 1.4 are indeterminate regarding well-controlled asthma. >80% predicted/ >80% (children aged 5 to 11 years) * 20 *For NIH definitions, see Figure 4-1a, Figure 4-1b, and Figure 4-5 of the Guidelines. National Heart, Lung, and Blood Institute. National Asthma Education and Prevention Program. Accessed April 17, EIB=exercise-induced bronchospasm; SABA=short-acting beta 2-agonist. National Heart, Lung, and Blood Institute. National Asthma Education and Prevention Program. Accessed April 17, Assessing Asthma Control in Children, Adolescents, and Adults Asthma Goals Exacerbations requiring oral systemic corticosteroids NIH Criteria for Well-Controlled Asthma: Risk Domain Progressive loss of lung function (youths 12 years and adults) or reduction in lung growth (children aged 5 to 11 years) Treatment-related adverse effects 0 to 1/year. Consider severity and interval since last exacerbation Evaluation requires long-term follow-up care Medication side effects can vary in intensity from none to very troublesome and worrisome. The level of intensity does not correlate to specific levels of control but should be considered in the overall assessment of risk NIH Asthma Guidelines recommended actions for well-controlled asthma include the following: Schedule regular follow-ups every 1 to 6 months to maintain control Consider step down if well controlled for at least 3 months Your clinical judgment is important in considering whether patients asthma is well controlled; consider both impairment and risk domains. Lead a happy, healthy normal life Participate in any sport (except SCUBA) Be active, run around and play Be able to sleep through the night without coughing No missed school or work Normal lung functions National Heart, Lung, and Blood Institute. National Asthma Education and Prevention Program. Accessed April 17, Allergy Central Allergic Diseases Marc W. Cromie Sr,, M.D. Chattanooga Allergy Clinic N e 7
8 Objectives Review diseases that can be allergic Describe allergy testing Discuss groups of allergens Review common allergy medicines Discuss treatment of allergic disease Answer questions Allergic Diseases Hay fever Asthma Anaphylaxis Eczema Hives Food reactions Drug reactions Insect sting reactions What is Allergy? Allergic reactions are marked by a very specific reaction by the immune system Triggered by otherwise harmless substances Characterized by release of histamine and other inflammatory chemicals Many physical reactions are not allergic Allergic Diseases For each of these diseases, some people have allergy as a trigger, some don t Evaluation by an allergist can help to identify allergies and assess their significance Allergy Diagnosis History Physical Exam Allergy Testing if indicated Skin testing Blood Testing Other tests as needed Spirometry Skin Testing Skin prick testing Intradermal testing Allergy Diagnosis 8
9 Pollens Common Allergens Fungi or Molds Common Allergens Trees Grasses Weeds Spring Summer Fall Common Allergens Indoor allergens Foods Common Allergens Dogs Cockroach Peanut Shrimp Egg Milk Cats Dust Mite Soy Fish Wheat Tree Nuts Common Allergens Common Allergens Drugs Penicillin Sulfa antibiotics Aspirin Insect Stings Hornet Fire Ant Yellow Jacket Paper Wasp 9
10 Common Irritants Not true allergens, but can cause problems Diseases caused by Allergies Hay fever Asthma Food allergy Anaphylaxis Perfume Chemicals Smoke Pollution Hay Fever Itchy, watery eyes Runny nose Post Nasal Drip Itchy Nose Sneezing Congestion Hay Fever Usually due to Allergies Early Spring- Tree pollen Late Spring/Summer- Grass Pollen Fall- Weed Pollen (like Ragweed!) Year round (dust mite, mold, pets) Can lead to school (and work) problems Absenteeism Presenteeism, sedation, poor performance Due to lack of sleep or medicine side effects The Allergic March Starts with food allergy or eczema Child then develops hay fever Asthma follows Asthma is a bad disease Can we prevent this? Maybe! Allergy Treatments Avoidance Pets Dust Mites Foods Drugs 10
11 Hay Fever Treatments Medications Nasal steroids Antihistamines Decongestants Eye drops Montelukast Nasal saline irrigations Allergy Shots Allergy Treatments Injections of things you re allergic to with slowly increasing doses Usually requires at least 3-5 years Induces changes in the immune system away from allergic reactions Not possible with foods or drugs May halt the Allergic March Allergy Treatments Food Allergy Allergy Drops and Allergy tablets Oral treatments (either under the tongue or tablets) Tablets recently FDA approved (grass tablets and ragweed tablets) Mostly for monosensitized patients Insurance may not pay for this treatment 25% of the population thinks they have food allergy 4-6% of children actually do have food allergy Less than 2% of adults have food allergy Mostly to peanuts, tree nuts, and seafood What is Food Allergy? What is Food Allergy? A colicky baby? A child with a stomach ache, bloating, and gas after eating ice cream? An infant with prolonged loose stools after rotavirus infections? A child with vomiting and diarrhea after eating potato salad at a picnic? A wired teenager after two liters of Jolt Cola? Allergy vs. Intolerance The immune system causes allergy Eczema, hives, anaphylaxis Many factors can cause intolerance Lactose intolerance, milk protein intolerance Galactosemia Celiac Disease 11
12 Food Allergy Diagnosis Food Allergy Diagnosis If food allergy is suspected, your allergist will: Skin test to the most common foods Skin test to any other suspected foods Possibly send blood work for food allergens Skin testing is more accurate and less expensive per test than blood Diagnosis of food allergy requires a positive test AND a positive history If a child has a positive test and can eat that food without problem, they can continue to eat that food cautiously Food Allergy Symptoms Food Allergy Eczema Hives Vomiting/Diarrhea Nasal symptoms Anaphylactic Shock Many food allergies will be outgrown: ~70% milk, wheat, and egg outgrown <15% peanut allergy outgrown 5% tree nut allergy outgrown Seafood and nut allergy often persist to adulthood Frequent cause of fatal anaphylaxis Anaphylaxis Deadly Allergy Signs of Anaphylaxis Increasingly common Can be due to foods, drugs, insect stings and many more Deaths are uncommon with RAPID treatment In most fatalities, there was a delay in recognition and in giving EpiPen % have hives or swelling Wheezing Voice changes Difficulty swallowing/throat swelling Vomiting/diarrhea (common with foods) Low blood pressure Loss of consciousness 12
13 Treatment of Anaphylaxis EpiPen, EpiPen, EpiPen Same thing as adrenaline Give EpiPen Jr for children under 60 pounds Seek medical care after giving Epi Liquid Benadryl Oral or IV steroids not as important initially Key Points- Anaphylaxis Know who is at risk Severe food allergy Insect sting allergy EpiPen or EpiPen Jr should be available at all times Field trips Outside during recess (esp with insect allergy) Have liquid Benadryl on hand Works faster than pills Key Points- Anaphylaxis If a child is severely food allergic: Make sure other children wash hands after eating this food Tables, desks and toys should be thoroughly washed after meals Parents should have option of bringing a safe goody bag for the food allergic child Other parents can be asked to avoid sending that type of food to class Marc Cromie, M.D. (423) The End Thank You! N e 13
Eczema: also called atopic dermatitis; a chronic, itchy, scaly rash not due to a particular substance exposure
Allergy is a condition in which the immune system causes sneezing, itching, rashes, and wheezing, or sometimes even life-threatening allergic reactions. The more you know about allergies, the better prepared
More informationImproving the Management of Asthma to Improve Patient Adherence and Outcomes
Improving the Management of Asthma to Improve Patient Adherence and Outcomes Robert Sussman, MD Atlantic Health System Overlook Medical Center Asthma Remains a Serious Health Risk in the US Every day in
More informationHealthPartners Care Coordination Clinical Care Planning and Resource Guide ASTHMA
The following evidence based guideline was used in developing this clinical care guide: National Institute of Health (NIH National Heart, Lung, and Blood Institute (NHLBI) and American Academy of Allergy,
More informationGet Healthy Stay Healthy
Asthma Management WHAT IS ASTHMA? Asthma causes swelling and inflammation in the breathing passages that lead to your lungs. When asthma flares up, the airways tighten and become narrower. This keeps the
More informationAsthma 2015: Establishing and Maintaining Control
Asthma 2015: Establishing and Maintaining Control Webinar for Michigan Center for Clinical Systems Improvement (Mi-CCSI) Karen Meyerson, MSN, APRN, NP-C, AE-C June 16, 2015 Asthma Prevalence Approx. 26
More informationAsthma Management for the Athlete
Asthma Management for the Athlete Khanh Lai, MD Assistant Professor Division of Pediatric Pulmonary and Sleep Medicine University of Utah School of Medicine 2 nd Annual Sports Medicine Symposium: The Pediatric
More informationAsthma With a Slight Chance of Anaphylaxis
Asthma With a Slight Chance of Anaphylaxis An Update for Alberta Oral Health Professionals Sept 25/13 Presented by Val Olson CRE Community Pediatric Asthma Service Air passes through the: Nose or mouth
More informationClinical Practice Guideline: Asthma
Clinical Practice Guideline: Asthma INTRODUCTION A critical aspect of the diagnosis and management of asthma is the precise and periodic measurement of lung function both before and after bronchodilator
More informationAsthma for Primary Care: Assessment, Control, and Long-Term Management
Asthma for Primary Care: Assessment, Control, and Long-Term Management Learning Objectives After participating in this educational activity, participants should be better able to: 1. Choose the optimal
More informationGlossary of Asthma Terms
HealthyKidsExpress@bjc.org Asthma Words to Know Developed in partnership with Health Literacy Missouri Airways (Bronchi, Bronchial Tubes): The tubes in the lungs that let air in and out of the body. Airway
More informationHealth Point: Understanding Allergic Reactions
Health Point: Understanding Allergic Reactions What are allergies? Every person s body is different. People s bodies can react differently to the same things. For example, you may like to eat fish, but
More informationSources. Taking Charge of Your Asthma. Asthma Action Plan (to be completed with your doctor) UnitedHealthcare Insurance Company
Asthma Action Plan (to be completed with your doctor) Green Zone: (80 to 00% of my personal best) Peak Flow between and (00% = personal best) You can do all the things you usually do. Your asthma medicine
More informationNancy Davis, RRT, AE-C
Nancy Davis, RRT, AE-C Asthma Statistics 25.6 million Americans diagnosed with asthma 6.8 million are children 10.5 million missed school days per year 14.2 lost work days for adults Approximately 10%
More informationFunction of the Respiratory System. Exchange CO2 (on expiration) for O2 (on inspiration)
Function of the Respiratory System Exchange CO2 (on expiration) for O2 (on inspiration) Upper Respiratory Tract Includes: Nose Mouth Pharynx Larynx Function: Warms and humidifies the inspired air Filters
More informationThe Asthma Guidelines: Diagnosis and Assessment of Asthma
The Asthma Guidelines: Diagnosis and Assessment of Asthma Christopher H. Fanta, M.D. Partners Asthma Center Brigham and Women s Hospital Harvard Medical School Objectives Know how the diagnosis of asthma
More informationPediatric Allergy Allergy Related Testing
Pediatric Allergy Allergy Related Testing 1 Allergies are reactions that are usually caused by an overactive immune system. These reactions can occur in a variety of organs in the body, resulting in conditions
More informationDiagnosis, Assessment, Monitoring and Pharmacological Treatment of Asthma
Diagnosis, Assessment, Monitoring and Pharmacological Treatment of Asthma Magnitude of Asthma - India Delhi Childhood asthma: 10.9% Adults: 8% Other Cities 3 to 18% Chhabra SK et al Ann Allergy Asthma
More informationClinical Implications of Asthma Phenotypes. Michael Schatz, MD, MS Department of Allergy
Clinical Implications of Asthma Phenotypes Michael Schatz, MD, MS Department of Allergy Definition of Phenotype The observable properties of an organism that are produced by the interaction of the genotype
More informationDoes rhinitis. lead to asthma? Does sneezing lead to wheezing? What allergic patients should know about the link between allergic rhinitis and asthma
Does rhinitis lead to asthma? Does sneezing lead to wheezing? What allergic patients should know about the link between allergic rhinitis and asthma For a better management of allergies in Europe Allergy
More informationAsthma By Mayo Clinic staff
MayoClinic.com reprints This single copy is for your personal, noncommercial use only. For permission to reprint multiple copies or to order presentation-ready copies for distribution, use the reprints
More informationDiagnosis, Treatment and Management of Asthma
Diagnosis, Treatment and Management of Asthma Asthma is a complex disorder characterized by variable and recurring symptoms, airflow obstruction, bronchial hyperresponsiveness, and an underlying inflammation.
More informationMANAGING ASTHMA. Nancy Davis, RRT, AE-C
MANAGING ASTHMA Nancy Davis, RRT, AE-C What is asthma? Asthma is a chronic respiratory disease characterized by episodes or attacks of inflammation and narrowing of small airways in response to asthma
More informationLEARN ABOUT ANOTHER WAY TO TREAT YOUR ALLERGIES
LEARN ABOUT ANOTHER WAY TO TREAT YOUR ALLERGIES WHAT ARE ALLERGIES? It s probably not something that you think about, but every time you open your mouth or inhale, tiny particles from the environment that
More informationAsthma in the Athlete
Asthma in the Athlete Jorge E. Gomez, MD Associate Professor Texas Children s Hospital Baylor College of Medicine Assist Team Physician UH Understand how we diagnose asthma Objectives Be familiar with
More informationSome Facts About Asthma
Some Facts About Asthma Contents What is asthma? Diagnosing asthma Asthma symptoms Asthma triggers Thanks What is asthma?? Asthma is a chronic lung-disease that inflames and narrows the airways (tubes
More informationAsthma. Guide to Good Health. Healthy Living Guide
Asthma Guide to Good Health Healthy Living Guide Asthma Chronic Fatigue Syndrome (CFS) Chronic Obstructive Pulmonary Disease (COPD) Coronary Artery Disease (CAD) Depression Hyperlipidemia Hypertension
More informationFood Allergy , The Patient Education Institute, Inc. imf10101 Last reviewed: 10/15/2017 1
Food Allergy Introduction A food allergy is an abnormal response to a food. It is triggered by your body's immune system. An allergic reaction to a food can sometimes cause severe illness or death. Tree
More informationSpeaker Disclosure. Identification and Diagnosis of Asthma. Definition of Asthma. Objectives 11/9/2017
Speaker Disclosure Identification and Diagnosis of Asthma Isabel L. Virella Lowell, MD, Associate Professor, Pulmonology and Sleep Medicine, University of Alabama at Birmingham Isabel Virella-Lowell, MD
More informationLearning the Asthma Guidelines by Case Studies
Learning the Asthma Guidelines by Case Studies Timothy Craig, DO Professor of Medicine and Pediatrics Distinguished Educator Penn State University Hershey Medical Center Objectives 1. Learn the Asthma
More informationASTHMA IN THE PEDIATRIC POPULATION
ASTHMA IN THE PEDIATRIC POPULATION SEARCH Rotation 2 August 23, 2010 Objectives Define asthma as a chronic disease Discuss the morbidity of asthma in pediatrics Discuss a few things that a health center
More informationWest Houston Allergy & Asthma, P.A.
Consent to Receive Immunotherapy (ALLERGY SHOTS) Procedure Allergy injections are usually started at a very low dose. This dose is gradually increased on a regular (usually 1-2 times per week) basis until
More informationPathology of Asthma Epidemiology
Asthma A Presentation on Asthma Management and Prevention What Is Asthma? A chronic disease of the airways that may cause Wheezing Breathlessness Chest tightness Nighttime or early morning coughing Pathology
More informationBreathe Easy. Living with Asthma
Breathe Easy Living with Asthma Got Asthma? You re Not Alone! More than 300 million people around the world have asthma. But having asthma doesn t have to limit what you can do. With education and treatment,
More informationPREPARATION FOR ALLERGY TESTING *** Please read this information at least one week before your upcoming visit.
PREPARATION FOR ALLERGY TESTING *** Please read this information at least one week before your upcoming visit. In order to obtain valid and useful skin testing results, you will need to stop the use of
More informationImproving asthma outcomes though education
Improving asthma outcomes though education Segment 1 Clinical Aspects of Asthma and Long term Plan Primary Care and Asthma Most common chronic disease of childhood. Primary care providers are expected
More informationAsthma and Vocal Cord Dysfunction
Asthma and Vocal Cord Dysfunction Amy L. Marks DO, FACOP Pediatric Allergy and Immunology Assistant Professor of Pediatrics Oakland University William Beaumont School of Medicine Objectives: Understanding
More informationAsthma in Pediatric Patients. DanThuy Dao, D.O., FAAP. Disclosures. None
Asthma in Pediatric Patients DanThuy Dao, D.O., FAAP Disclosures None Objectives 1. Discuss the evaluation and management of asthma in a pediatric patient 2. Accurately assess asthma severity and level
More informationSpirometry Workshop for Primary Care Nurse Practitioners
Spirometry Workshop for Primary Care Nurse Practitioners Catherine Casey S. Jones PhD, RN, AE-C, ANP-C Certified Adult Nurse Practitioner Texas Pulmonary & Critical Care Consultants P.A. and Adjunct Professor
More information1
1 2 3 4 5 6 Scratch and Sniff All About Allergies Doug Jones, MD Program Director, Family Medicine, DHMG What is an allergic reaction? The immune system identifies things that are foreign and protects
More informationMost common chronic disease in childhood Different phenotypes:
Dr. W. Wijnant Paediatric Pulmonology Steve Biko Academic Hospital Most common chronic disease in childhood Different phenotypes: Viral wheezer Multiple trigger wheezer Transient wheezer Persistent early
More informationKickin Asthma. Workbook for Children with Asthma. Name:
Kickin Asthma Workbook for Children with Asthma Name: Why Have You Been Invited to Kickin Asthma? You have been invited to Kickin Asthma because you have asthma. Asthma is a disease of your air tubes that
More informationAir Flow Limitation. In most serious respiratory disease, a key feature causing morbidity and functional disruption is air flow imitation.
Asthma Air Flow Limitation In most serious respiratory disease, a key feature causing morbidity and functional disruption is air flow imitation. True whether reversible, asthma and exercise-induced bronchospasm,
More informationAsthma Description. Asthma is a disease that affects the lungs defined as a chronic inflammatory disorder of the airways.
Asthma Asthma Description Asthma is a disease that affects the lungs defined as a chronic inflammatory disorder of the airways. Symptoms of asthma In susceptible individuals, this inflammation causes recurrent
More informationYour Guide to MANAGING ASTHMA
Your Guide to MANAGING ASTHMA Asthma affects more than 24 MILLION AMERICANS. It is a chronic disease that causes your airways to become inflamed, making it hard to breathe. There is no cure for asthma.
More informationAsthma in Pregnancy. Asthma. Chronic Airway Inflammation. Objective Measures of Airflow. Peak exp. flow rate (PEFR)
Chronic Airway Inflammation Asthma in Pregnancy Robin Field, MD Maternal Fetal Medicine Kaiser Permanente San Francisco Asthma Chronic airway inflammation increased airway responsiveness to a variety of
More informationDoes yours? Most school-age kids with asthma have allergic asthma. Enroll in our support program. Learn about this distinct condition
Most school-age kids with asthma have allergic asthma. Does yours? Learn about this distinct condition Enroll in our support program for tools, information on financial resources, and more at GetSupportForYou.com
More informationAsthma 101. Introduction
TRIGGERS Introduction Asthma is a chronic disease of the lungs that makes it difficult for people to breathe. Asthma is extremely common. About 20 million Americans have asthma. About 5,000 die each year
More informationAsthma. The prevalence of asthma has been increasing worldwide, but why this is happening is not known.
Asthma What is asthma? Asthma is a chronic disorder of the airways of the lungs. The airways are reactive and may be inflamed even when symptoms are not present. The extent and severity of airway irritation
More informationRecognition & Management of Anaphylaxis in the Community. S. Shahzad Mustafa, MD, FAAAAI
Recognition & Management of Anaphylaxis in the Community S. Shahzad Mustafa, MD, FAAAAI Disclosures None Outline Define anaphylaxis Pathophysiology Common causes Recognition and Management Definition Acute,
More informationAllergy Management Policy
Allergy Management Policy Food Allergy People with allergies have over-reactive immune systems that target otherwise harmless elements of our diet and environment. During an allergic reaction to food,
More informationName: Date: How were you referred? Physician Other Self Referral. What problem brings you or your child to this appointment?
Name: Date: How were you referred? Physician Other Self Referral What problem brings you or your child to this appointment? What did the symptoms begin? Are your symptoms getting worse? Circle: Yes or
More informationAmanda Hess, MMS, PA-C President-Elect, AAPA-AAI Arizona Asthma and Allergy Institute Scottsdale, AZ
Amanda Hess, MMS, PA-C President-Elect, AAPA-AAI Arizona Asthma and Allergy Institute Scottsdale, AZ Financial Disclosures Advanced Practiced Advisory Board for Circassia Learning Objectives 1. Briefly
More informationEffective Date: 4/27/2016 Version: 1.0 Approval By: CCC Clinical Delivery Steering Planned Review Date: 4/27/2017
Protocol Title: Adult Asthma Protocol Effective Date: 4/27/2016 Version: 1.0 Approval By: CCC Clinical Delivery Steering Planned Review Date: 4/27/2017 1 Purpose & Objective This protocol provides evidence-based
More informationNew Patient Questionnaire
- - Toda y 's Date: Primary Care Provider's Name: Was a consultation recommended? Primary Clinic: Referring provider's name (if different): Please answer the following questions to facilitate the diagnosis
More informationI have no perceived conflicts of interest or commercial relationships to disclose.
ASTHMA BASICS Michelle Dickens RN FNP-C AE-C Nurse Practitioner/Certified Asthma Educator Ferrell Duncan Allergy/Asthma/Immunology Coordinator, CoxHealth Asthma Center DISCLOSURES I have no perceived conflicts
More informationPath2220 INTRODUCTION TO HUMAN DISEASE ALLERGY. Dr. Erika Bosio
Path2220 INTRODUCTION TO HUMAN DISEASE ALLERGY Dr. Erika Bosio Research Fellow Centre for Clinical Research in Emergency Medicine, Harry Perkins Institute of Medical Research University of Western Australia
More informationOptimal Assessment of Asthma Control in Clinical Practice: Is there a role for biomarkers?
Disclosures: Optimal Assessment of Asthma Control in Clinical Practice: Is there a role for biomarkers? Stanley Fineman, MD Past-President, American College of Allergy, Asthma & Immunology Adjunct Associate
More informationPediatric Asthma Management
Pediatric Asthma Management APRN Conference February 2016 Cheryl Kerrigan, MSN, CPNP Aimee Tiller RN, AE-C The Plan Definition Pathophysiology review Triggers & Risk Factors Incidence and Prevalence Making
More information9220 Haven Avenue, Suite 101 Rancho Cucamonga, CA Tel: (909) Fax: (909) ALLERGY HISTORY
Name: Date of Birth: Date of Visit: Briefly describe the reason for your visit: How long have you had these problems? How frequently do you have them? NASAL SYMPTOMS ALLERGY HISTORY 1. I have the following
More informationAsthma and IAQ. Lani Wheeler, MD, Medical Officer Sarah Merkle, MPH, Program Analyst
Asthma and IAQ Lani Wheeler, MD, Medical Officer Sarah Merkle, MPH, Program Analyst Division of Adolescent and School Health Centers for Disease Control and Prevention Asthma is a Major Public Health Problem
More informationManagement of ANAPHYLAXIS in the School Setting. Updated September 2010
Management of ANAPHYLAXIS in the School Setting Updated September 2010 What is an Allergy? Allergies occur when the immune system becomes unusually sensitive and over reacts to common substance that are
More informationOn completion of this chapter you should be able to: discuss the stepwise approach to the pharmacological management of asthma in children
7 Asthma Asthma is a common disease in children and its incidence has been increasing in recent years. Between 10-15% of children have been diagnosed with asthma. It is therefore a condition that pharmacists
More informationBronchial asthma. E. Cserháti 1 st Department of Paediatrics. Lecture for english speaking students 5 February 2013
Bronchial asthma E. Cserháti 1 st Department of Paediatrics Lecture for english speaking students 5 February 2013 Epidemiology of childhood bronchial asthma Worldwide prevalence of 7-8 and 13-14 years
More informationAsthma. UVM. University of Vermont. Alicia Jacobs MD Fletcher Allen Health Care and the University of Vermont
University of Vermont ScholarWorks @ UVM Family Medicine Scholarly Works 6-14-2013 Asthma Alicia Jacobs MD Fletcher Allen Health Care and the University of Vermont Follow this and additional works at:
More informationAilléirge Péidiatraiceach. Pediatric Allergy 3/9/2018. Disclosures & Conflicts Of Interest
Ailléirge Péidiatraiceach Michael Zacharisen, M.D. Allergy/Immunology Pediatric Allergy Michael Zacharisen, M.D. Allergy/Immunology Disclosures & Conflicts Of Interest Green Bay Packer fan I drive a Jeep
More informationMyth: Prior Episodes Predict Future Reactions REALITY: No predictable pattern Severity depends on: Sensitivity of the individual Dose of the allergen
Myth: Prior Episodes Predict Future Reactions REALITY: No predictable pattern Severity depends on: Sensitivity of the individual Dose of the allergen Anaphylaxis Fatalities Estimated 500 1000 deaths annually
More informationDiagnosis. you have asthma? Get the answers. Your Asthma Basics series: Asthma Basics #1. Diagnosis Triggers Medications Kids
Diagnosis Asthma Basics #1 Your Asthma Basics series: 1 2 3 Diagnosis Triggers Medications Kids Supported by unrestricted educational grants from: For more information from the Asthma Society of Canada:
More informationASTHMA CONTROL. Asthma is a chronic airway disease. You cannot cure asthma, but you can control it. Treatment can improve asthma symptoms.
ASTHMA CONTROL Asthma is a chronic airway disease. You cannot cure asthma, but you can control it. Treatment can improve asthma symptoms. Asthma changes the lung airways in 3 ways: 1. Lining of the airways
More informationyour triggers? Information about a simple lab test that lets you Know Your IgE.
What your are CAT DANDER DUST MITE triggers? Knowing if you have allergic triggers can help you manage your symptoms. Know yours and take control. OAK Information about a simple lab test that lets you
More informationAsthma. Definition. Symptoms
Asthma Definition Asthma is a condition in which your airways narrow and swell and produce extra mucus. This can make breathing difficult and trigger coughing, wheezing and shortness of breath. For some
More informationAsthma Education. The Keys to Asthma Prevention and Control. what to do when one s asthma is flared! Lucile Packard Children s Hospital.
Asthma Education Lucile Packa r d Children s H o spit al Created by Rachel Lawler RN, MSN, cpnp, AE-C, NPAT Pulmonary Pediatric Nurse Practitioner Lucile Packard Children s Hospital The Keys to Asthma
More informationPresented by the California Academy of Family Physicians 2013/California Academy of Family Physicians
Family Medicine and Patient-Centered Asthma Care Presented by the California Academy of Family Physicians Faculty: Hobart Lee, MD Disclosures: Jeffrey Luther, MD, Program Director, Memorial Family Medicine
More information(Asthma) Diagnosis, monitoring and chronic asthma management
Dubai Standards of Care 2018 (Asthma) Diagnosis, monitoring and chronic asthma management Preface Asthma is one of the most common problem dealt with in daily practice. In Dubai, the management of chronic
More informationNG80. Asthma: diagnosis, monitoring and chronic asthma management (NG80)
Asthma: diagnosis, monitoring and chronic asthma management (NG80) NG80 NICE has checked the use of its content in this product and the sponsor has had no influence on the content of this booklet. NICE
More informationAsthma Management Protocol
Asthma Management Protocol USC School of Pharmacy Updated October 2012 08/24/18 USC School of Pharmacy 1 I. Goals and Objectives The goal of the pharmacist-managed Asthma Management Program (AMP) is to
More informationThis is a cross-sectional analysis of the National Health and Nutrition Examination
SUPPLEMENTAL METHODS Study Design and Setting This is a cross-sectional analysis of the National Health and Nutrition Examination Survey (NHANES) data 2007-2008, 2009-2010, and 2011-2012. The NHANES is
More informationAsthma Update A/Prof. John Abisheganaden. Senior Consultant, Dept Of Respiratory & Crit Care Medicine Tan Tock Seng Hospital
Asthma Update - 2013 A/Prof. John Abisheganaden Senior Consultant, Dept Of Respiratory & Crit Care Medicine Tan Tock Seng Hospital Asthma A complex syndrome Multifaceted disease Heterogeneous Genetic and
More informationMedical History Form
Dr. Vivek U. Rao, M.D. 500 Adams Ave., Suite 300 Odessa, TX 79761 Phone: 432.333.3300 Fax: 432.339.3300 Medical History Form Patient Name: DOB: A. CHIEF COMPLAINT: Briefly describe your (or your child
More informationGlen Ellyn Pharmacy Complementary Asthma Management Program Initial Visit
Asthma Project Goals: Decrease hospitalizations Decrease use of asthma medications Increase peak flow readings Improve quality of life Decrease doctor visits Page 1 of 10 Page 2 of 10 Patient Name: Patient
More informationMMO CLINIC MAYO CLINIC
MMO CLINIC Overview Allergies occur when your immune system reacts to a foreign substance such as pollen, bee venom or pet dander or to a food that doesn't cause a reaction in most people. Your immune
More informationPatient (Parent) Questionnaire Patient s Name: DOB: Date: Referred By: Primary Care Physician:
Dr. Bina Joseph Patient (Parent) Questionnaire Patient s Name: DOB: Date: Referred By: Primary Care Physician: Describe each problem that has led you to seek this allergy evaluation: 1. 2. 3. 4. Drug Allergies:
More information1 I *********IF YOU ARE NOT ON ALLERGY SHOTS PLEASE SKIP THIS SECTION AND MOVE TO PAGE 2********* NAME: AGE: ---- ID (For Office Use Only):
NAME: AGE: ---- Date of Appointment:. ID (For Office Use Only): RETURN VISIT Date of Visit: Main Reason for visit: Reevaluation Family Doctor: Symptoms worse _ New problem _ Yearly follow up _ Follow up/office
More informationDiagnosis and Management of Asthma in Children based on the British Thoracic Society and Scottish Intercollegiate Guidelines Network September 2016
Diagnosis and Management of Asthma in Children based on the British Thoracic Society and Scottish Intercollegiate Guidelines Network September 2016 Diagnosis: There is no lower limit to the age at which
More informationAsthma COPD Overlap (ACO)
Asthma COPD Overlap (ACO) Dr Thomas Brown Consultant Respiratory Physician Thomas.Brown@porthosp.nhs.uk Dr Hitasha Rupani Consultant Respiratory Physician Hitasha.rupani@porthosp.nhs.uk What is Asthma
More informationBreathe Easy. Tips for controlling your Asthma
Breathe Easy Tips for controlling your Asthma Have you or a family member been told you have asthma? Are you or a family member coughing or wheezing? Do you or a family member have tightness in your chest?
More informationASTHMA BEST PRACTICES FOR SCHOOL NURSES. School Nurses November 2015
ASTHMA BEST PRACTICES FOR SCHOOL NURSES School Nurses November 2015 1 BACKGROUND AND CURRENT STATS General definitions and explanations 2 Incidence of Asthma Centers for Disease Control (CDC) - 1 in 12
More informationExhaled Nitric Oxide Today s Asthma Biomarker. Richard F. Lavi, MD FAAAAI FAAP
Exhaled Nitric Oxide Today s Asthma Biomarker Richard F. Lavi, MD FAAAAI FAAP Objectives Describe exhaled nitric oxide physiology and pathophysiology Review the current literature regarding exhaled nitric
More informationRESPIRATORY CARE IN GENERAL PRACTICE
RESPIRATORY CARE IN GENERAL PRACTICE Definitions of Asthma and COPD Asthma is due to inflammation of the air passages in the lungs and affects the sensitivity of the nerve endings in the airways so they
More informationPrimary Care Medicine: Concepts and Controversies Wed., February 17, 2010 Fiesta Americana Puerto Vallarta, Mexico Update on Asthma and COPD
Primary Care Medicine: Concepts and Controversies Wed., February 17, 2010 Fiesta Americana Puerto Vallarta, Mexico Update on Asthma and COPD Talmadge E. King, Jr., M.D. Krevins Distinguished Professor
More informationAsthma Management. Photo from
Asthma Management 1 Photo from www.nhlbi.nih.gov Course Overview 1. Recognition of the symptoms and signs Basic Knowledge of asthma Recognition of common symptoms Recognition of the signs of asthma including
More informationLivingWith Asthma. A Guide to Understanding Asthma...
A Guide to Understanding... LivingWith Understanding Diagnosing Treating Frequently Asked Questions [2] A Guide to Understanding... Understanding What Is? (AZ-muh) is a chronic disease that affects your
More informationInhaler Confusion. Today s Speaker Dr. Randall Brown. Director of Asthma Programs 6/7/2016. Dr. Randall Brown March 31, 2016
+ Inhaler Confusion Dr. Randall Brown March 31, 2016 + Today s Speaker Dr. Randall Brown Director of Asthma Programs Center for Managing Chronic Disease University of Michigan 1 ASTHMA ESSENTIALS IN PRIMARY
More informationCold, Flu, or Allergy?
A monthly newsletter from the National Institutes of Health, part of the U.S. Department of Health and Human Services October 2014 Cold, Flu, or Allergy? Know the Difference for Best Treatment You re feeling
More informationXolair (Omalizumab) Drug Prior Authorization Protocol (Medical Benefit & Part B Benefit)
Line of Business: All Lines of Business Effective Date: August 16, 2017 Xolair (Omalizumab) Drug Prior Authorization Protocol (Medical Benefit & Part B Benefit) This policy has been developed through review
More informationAsthma ASTHMA. Current Strategies for Asthma and COPD
Current Strategies for Asthma and COPD Talmadge E. King, Jr., M.D. Krevins Distinguished Professor of Medicine Chair, Department of Medicine University of California San Francisco (UCSF) San Francisco,
More information(pedi) Patient Name: date of birth:
(pedi) Patient Name: date of birth:_ Date: I am being seen on: a) self referral _ b) physician referral from Dr. Please share the main reasons for your office visit today (check all those that apply):
More informationRespiratory Health. Asthma and COPD
Respiratory Health Asthma and COPD Definition of asthma Working definition by AAH 2014: Chronic lung disease Can be controlled not cured Large variation in lung function Large variation in respiratory
More informationAdult asthma management: focus on control
Adult asthma management: focus on control Jennifer W. McCallister, MD Associate Professor Pulmonary, Allergy, Critical Care & Sleep Medicine The Ohio State University Wexner Medical Center Objectives Apply
More informationMANAGEMENT OF ASTHMA SPRING Presented by:
MEDS@Work MANAGEMENT OF ASTHMA SPRING 2013 Presented by: Lusia Fomuso PharmD candidate 2014 Olivia Sibailly PharmD candidate 2014 Kimberly Biedka PharmD candidate 2014 Dr. Donna Bartlett PharmD CGP RPh
More informationManaging Allergies and Anaphylaxis at School EPI-PEN TRAINING FOR SCHOOL PERSONNEL
Managing Allergies and Anaphylaxis at School EPI-PEN TRAINING FOR SCHOOL PERSONNEL Objective: Attendees will be able to: Increase their knowledge about allergies to food and other allergens. Describe the
More information